XETR
SHL
Market cap44bUSD
Jun 18, Last price
34.43EUR
1D
-0.63%
1Q
-5.80%
IPO
10.60%
Name
Siemens Healthineers AG
Chart & Performance
P/E
19.84
P/S
1.72
EPS
1.74
Div Yield, %
2.76%
Shrs. gr., 5y
2.35%
Rev. gr., 5y
9.02%
Revenues
22.36b
+3.15%
Net income
1.94b
+28.69%
CFO
2.47b
+16.52%
Dividend
Feb 06, 20261 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. The company's operations are structured into four distinct divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging division specializes in advanced medical imaging technologies, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray equipment, molecular imaging techniques, and ultrasound systems. Within the Diagnostics division, the focus is on supplying in-vitro diagnostic solutions and services to healthcare professionals across various settings, including laboratory, molecular, and point-of-care environments. It also delivers laboratory workflow optimization tools and informatics solutions. The Varian segment is dedicated to oncology, furnishing cancer care technologies, comprehensive solutions, and support services to hospital and clinic oncology departments. This includes advanced workflow optimization through technology, expert clinical services and consultancy, as well as digital tools and applications designed to streamline and oversee patient treatment and therapy protocols. The Advanced Therapies division delivers products engineered to facilitate image-guided, minimally invasive procedures in fields such as cardiology, interventional radiology, and surgery. Its offerings extend to angiography systems and mobile C-arms, notably featuring a robotic-assisted platform for endovascular interventions involving coronary and peripheral vasculature. Beyond these core segments, Siemens Healthineers also offers a suite of supplementary services. These comprise managing equipment performance, clinical training and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare institutions, alongside consulting and digital health solutions. Headquartered in Erlangen, Germany, Siemens Healthineers AG functions as a subsidiary of Siemens Aktiengesellschaft.
IPO date
Mar 16, 2018
Employees
70,800
Domiciled in
DE
Incorporated in
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||